about
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory DiseasesTo Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory TherapiesTreating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesPharmacokinetic/pharmacodynamic modeling in inflammationThe multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cellsTherapeutic potential of monoacylglycerol lipase inhibitorsExpanding the clinical indications for α(1)-antitrypsin therapyA new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseasesNeuroinflammation in overnutrition-induced diseasesNeutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection.Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammationA Dormant Microbial Component in the Development of PreeclampsiaImaging Nanotherapeutics in Inflamed Vasculature by Intravital MicroscopyInitial steps of metastasis: cell invasion and endothelial transmigrationProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeDocosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphologyTranslational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory DiseasesA Zebrafish Drug-Repurposing Screen Reveals sGC-Dependent and sGC-Independent Pro-Inflammatory Activities of Nitric OxidecAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-productsInnate immune response of human alveolar macrophages during influenza A infectionPre-treatment of recombinant mouse MFG-E8 downregulates LPS-induced TNF-α production in macrophages via STAT3-mediated SOCS3 activationNovel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's DiseasePIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signalingThe dysfunctional host response to influenza A H7N9: a potential treatment option?Cell membrane-formed nanovesicles for disease-targeted delivery.Exploring the Potential of Venom from Nasonia vitripennis as Therapeutic Agent with High-Throughput Screening ToolsHistone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.Differential activation of endocrine-immune networks by arthritis challenge: Insights from colony-specific responsesPathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.Design, synthesis, and biological evaluation of a biyouyanagin compound libraryExperimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells.Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis.Porcine coronin 1A contributes to nuclear factor-kappa B (NF-κB) inactivation during Haemophilus parasuis infection.The resolution of inflammation: the devil in the flask and in the details.Interleukin-1 receptor blockade in perinatal brain injury.Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits.In search of magic bullets: the golden age of immunotherapeutics.Promoter RNA links transcriptional regulation of inflammatory pathway genes.The interleukin-1 family: back to the futureSynthesis and biological evaluation of novel indole-2-one and 7-aza-2-oxindole derivatives as anti-inflammatory agents.
P2860
Q26739120-9940BF9E-5516-43DF-8F6E-9CB248F223FBQ26786973-83950A4B-42F1-4E2F-9C20-75EE613007C2Q26799747-C531610C-DFAC-41AE-AD91-BDE1AD9E436DQ26830621-0642121B-91A3-4ECD-8155-592E8B9E9D58Q26858844-EA150979-A402-491E-8723-F291785ABE7FQ26991513-29EB020E-9697-4BE6-BCEE-D1346187AB8AQ27000764-2F729CD5-86B9-443C-895E-66892DF39CBBQ27005806-E080C0B9-E643-475F-8D29-8D44D95A1CDDQ27013624-40FCC528-716B-45AC-A587-281EB2E81CDEQ27341910-695F8CBD-A166-4601-855A-5DBCC4F03738Q27700060-94FA2FAB-EACC-4803-99C3-629C1AEA8518Q28069689-F712BBB4-E778-490B-BF3D-457208D64FC2Q28080268-76A75362-0654-4B9C-8633-04C7EDB2594AQ28238397-40A626EC-F199-452A-914E-9C09E5BC5546Q28387661-ACD11E78-BC23-4A0C-B09E-4DF9E38918C7Q28388907-62AEFA54-4BEF-4718-AF71-B2021BE9641EQ28548580-5C40A3C2-A2AE-4917-8A3C-2ECB0809773CQ28550118-713C27A0-0BF3-4712-A69C-5CD46AC88583Q28587417-AEEB4AAC-BF1E-4D86-BB95-C1C37C1BCCE2Q28731580-E7193E54-3C46-4BFA-8B40-2FC1FA7D29EBQ28742712-53BF3A16-26D5-4A0E-A9AF-8AD735D6A8B6Q28828576-212EA0A0-4A09-42BB-A11F-C99B1161941FQ28833590-08D23FF9-50EE-4C7B-A8C4-1A2C0DE6F02EQ30364777-8C460096-873E-4F3D-A8CC-F87D94DDBCD0Q30708969-521F600D-F154-40F3-BD90-49F4907F8755Q33360864-64B3B2BA-F4D3-4634-A0AC-160022754390Q33614697-4A94B24B-8378-49C0-BB4F-68B87576A487Q33673998-8552DA1A-B076-4F31-886D-CB36861B29AAQ33742612-FEF7D56D-E619-49A7-B741-80FFF37BEE71Q33796299-031D6F6E-AD87-45F5-BD84-BED1381A3B62Q33815955-C77C05AB-054C-498F-894D-73B509258B4EQ33828002-FFC22322-3D1C-4354-BDE3-47529EE13BABQ34004740-C5BD2C6C-5EC9-4F7C-A17A-5BA844A96387Q34181437-A9091CB0-FEE5-48C0-BFBD-8ABD38591968Q34297349-AC4789D0-271A-4822-A8BF-39A69BFBC665Q34343339-FF0FB2E7-06D6-402D-A875-058680FAA944Q34356481-7CC51B1C-0F43-4DDC-98F0-E0DA17AE6036Q34368214-4308BA56-13DE-4DE4-9C89-049307C2D53AQ34391415-585B61CE-AFFE-4323-8E89-94F91002ABA1Q34394336-1F85D1BC-14BD-47C9-A070-95BDCF0C30F2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Anti-inflammatory Agents: Present and Future
@en
Anti-inflammatory Agents: Present and Future.
@nl
type
label
Anti-inflammatory Agents: Present and Future
@en
Anti-inflammatory Agents: Present and Future.
@nl
prefLabel
Anti-inflammatory Agents: Present and Future
@en
Anti-inflammatory Agents: Present and Future.
@nl
P2860
P1433
P1476
Anti-inflammatory Agents: Present and Future
@en
P2860
P304
P356
10.1016/J.CELL.2010.02.043
P407
P577
2010-03-01T00:00:00Z